» Articles » PMID: 25704314

Low Level Laser Therapy Against Radiation Induced Oral Mucositis in Elderly Head and Neck Cancer Patients-a Randomized Placebo Controlled Trial

Overview
Specialty Biology
Date 2015 Feb 24
PMID 25704314
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Radiotherapy (RT) is treatment of choice for Elderly Head and Neck Cancer (HNC) patients. Oral mucositis (OM) during RT affects patient's routine oral activities and overall health. Low Level Laser Therapy (LLLT) provided some promising results against cancer therapy induced OM in children and adults. No study specifically evaluated effects of LLLT against RT induced OM in elderly HNC patients until date, hence we did this study.

Material And Methods: This double blinded study randomized 46 elderly HNC patients scheduled for RT [Dosage=66 Gray (2 Gy/fraction), 5 fractions/week, total 33 fractions for 6.5 weeks], into laser (22) and placebo (24) groups. Laser group patients received LLLT [Helium-Neon, λ=632.8 nm, power density=0.024 W/cm(2), dosage=3.0 J/point at six anatomical sites bilaterally i.e. 12 locations, total dose/session=36 J, beam aperture diameter=0.6 mm, beam spot size=1 cm(2), irradiated area diameter=1 cm(2), irradiation time/point=125 s, 5 sessions/week, non-contact method-distance between probe and irradiated tissues <1 cm, whereas placebo group did not receive laser. OM grades (RTOG/EORTC Scale), oral pain, weight loss, need for morphine analgesics and tube feeding, and RT break were recorded by a blinded assessor. Descriptive statistics and repeated measures ANOVA were used for analysis keeping p<0.05.

Results: Significant reduction in the incidence and duration of severe OM (p=0.016) and severe pain (p=0.023) and weight loss (p=0.004) was observed in laser than placebo group. No difference was found for enteral feeding use (p=0.667) between two groups.

Conclusions: LLLT decreased the severity of OM and oral pain in elderly HNC patients. Also, lesser weight loss, morphine analgesic use and radiation break happened in laser group.

Citing Articles

Preventive Photobiomodulation for Chemotherapy-Induced Oral Mucositis: A Systematic Review of Randomized Clinical Trials.

Parra-Rojas S, Velazquez-Cayon R, Ciortan-Pop M, Martins M, Cassol Spanemberg J Biomedicines. 2025; 13(2).

PMID: 40002682 PMC: 11852607. DOI: 10.3390/biomedicines13020268.


Gold nanoparticles as innovative therapeutics for oral mucositis: A review of current evidence.

Choudhury M, Brunton P, Dias G, Schwass D, Meledandri C, Ratnayake J Drug Deliv Transl Res. 2024; .

PMID: 39625578 DOI: 10.1007/s13346-024-01748-x.


Photobiomodulation for the prevention and treatment of oral mucositis in patients submitted to hematopoietic stem cell transplantation: health quality evaluation.

Marinho L, Freire G, Silva D, de Lima K, da Silveira E, Potter G Support Care Cancer. 2024; 32(11):760.

PMID: 39480546 DOI: 10.1007/s00520-024-08952-y.


Therapeutic Outcomes of Photobiomodulation in Cancer Treatment-induced Oral Mucositis: A Systematic Review.

Sanchez-Martos R, Lamdaoui W, Arias-Herrera S J Clin Exp Dent. 2023; 15(9):e749-e759.

PMID: 37799759 PMC: 10550082. DOI: 10.4317/jced.60710.


Quality assessment of PBM protocols for oral complications in head and neck cancer patients: part 2.

Gobbo M, Arany P, Merigo E, Bensadoun R, Santos-Silva A, Gueiros L Support Care Cancer. 2023; 31(5):306.

PMID: 37115315 DOI: 10.1007/s00520-023-07749-9.